Beijing Strong Biotechnologies, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001Y26
CNY
11.75
-0.78 (-6.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
334.81
343.79
343.38
348.53
319.81
421.54
415.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
334.81
343.79
343.38
348.53
319.81
421.54
415.67
Raw Material Cost
60.47
90.46
81.63
88.09
74.23
97.41
103.57
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.44
13.25
12.37
11.88
11.94
12.16
12.06
Selling and Distribution Expenses
100.28
97.22
97.02
111.56
95.86
95.45
118.82
Other Expenses
2.81
3.53
2.58
2.44
2.61
4.14
2.50
Total Expenditure (Excl Depreciation)
201.30
236.28
216.78
235.97
208.10
246.42
259.50
Operating Profit (PBDIT) excl Other Income
133.5
107.5
126.6
112.6
111.7
175.10000000000002
156.2
Other Income
8.25
23.81
1.62
2.23
2.95
24.89
1.50
Operating Profit (PBDIT)
136.42
139.41
141.02
128.22
127.95
209.72
171.42
Interest
12.44
13.25
12.37
11.88
11.94
12.16
12.06
Exceptional Items
0.00
-174.77
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
274.34
253.34
261.75
260.44
245.58
324.12
312.10
Depreciation
0.00
18.07
18.07
17.98
17.98
18.40
18.40
Profit Before Tax
123.98
-66.69
110.58
98.36
98.02
179.16
140.96
Tax
18.37
11.82
13.22
6.22
14.45
20.40
18.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
105.61
-82.59
97.23
91.98
83.26
159.25
123.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
105.61
-82.59
97.23
91.98
83.26
159.25
123.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.05
0.13
0.17
0.32
-0.49
-0.20
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
105.61
-82.53
97.36
92.14
83.57
158.76
122.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,891.39
3,788.02
4,000.38
4,078.02
4,219.98
4,138.37
3,970.74
Earnings per share (EPS)
0.18
-0.14
0.17
0.16
0.14
0.27
0.21
Diluted Earnings per share
0.18
-0.14
0.17
0.16
0.14
0.27
0.21
Operating Profit Margin (Excl OI)
38.28%
28.37%
35.33%
30.99%
33.46%
39.48%
36.45%
Gross Profit Margin
37.03%
-14.14%
37.47%
33.38%
36.27%
46.87%
38.34%
PAT Margin
31.54%
-24.02%
28.31%
26.39%
26.03%
37.78%
29.59%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.62% vs 0.12% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 228.00% vs -184.70% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 10.90% vs -17.07% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -6.06% vs 6.45% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Beijing Strong Biotechnologies, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
334.81
0
334.81
Other Operating Income
0.00
0.00
0.00
Total Operating income
334.81
0
334.81
Raw Material Cost
60.47
0
60.47
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.44
0
12.44
Selling and Distribution Expenses
100.28
0
100.28
Other Expenses
2.81
0.00
2.81
Total Expenditure (Excl Depreciation)
201.30
0
201.30
Operating Profit (PBDIT) excl Other Income
133.51
0.00
133.51
Other Income
8.25
0
8.25
Operating Profit (PBDIT)
136.42
0
136.42
Interest
12.44
0
12.44
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
274.34
0
274.34
Depreciation
0.00
0
0.00
Profit Before Tax
123.98
0
123.98
Tax
18.37
0
18.37
Provisions and contingencies
0
0
0.00
Profit After Tax
105.61
0
105.61
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
105.61
0
105.61
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
105.61
0
105.61
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,891.39
0
3,891.39
Earnings per share (EPS)
0.18
0
0.18
Diluted Earnings per share
0.18
0
0.18
Operating Profit Margin (Excl OI)
38.28%
0%
0.00
38.28%
Gross Profit Margin
37.03%
0%
0.00
37.03%
PAT Margin
31.54%
0%
0.00
31.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 33.48 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.62% vs 0.12% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.69% vs -18.81% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.56 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 228.00% vs -184.70% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 26.32% vs -30.45% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.82 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 10.90% vs -17.07% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.56% vs -26.56% in Mar 2025

Quarterly - Interest
Interest 1.24 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.06% vs 6.45% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.20% vs 0.85% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.28%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025